Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse

Clinical trial NCT00573534 · COMPLETED

Trial details

NCT number: NCT00573534
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2008-03-01
Primary completion: 2010-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.